Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Koszycki D

Collect these papers and discover other ones on Labmeeting. Learn more.

Prenatal social support, postnatal social support, and postpartum depression.

+ cite this

+ View Abstract

Xie RH, He G, Koszycki D, Walker M, and Wen SW

Annals of epidemiology 19(9):637-43, 2009 Sep - Who cited this? | PubMed ID: 19443240 | Fulltext

Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder.

+ cite this

+ View Abstract

Koszycki D, Benger M, Shlik J, and Bradwejn J

Behaviour research and therapy 45(10):2518-26, 2007 Oct - Who cited this? | PubMed ID: 17572382 | Fulltext

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

+ cite this

+ View Abstract

Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, and CREATE Investigators

JAMA : the journal of the American Medical Association 297(4):367-79, 2007 Jan 24 - Who cited this? | PubMed ID: 17244833 | Fulltext

Evaluation of anxiolytic properties of Gotukola--(Centella asiatica) extracts and asiaticoside in rat behavioral models.

+ cite this

+ View Abstract

Wijeweera P, Arnason JT, Koszycki D, and Merali Z

Phytomedicine : international journal of phytotherapy and phytopharmacology 13(9-10):668, 2006 Nov - Who cited this? | PubMed ID: 16488124 | Fulltext

Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.

+ cite this

+ View Abstract

Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, and Kennedy JL

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 31(10):2237, 2006 Oct - Who cited this? | PubMed ID: 16525418 | Fulltext

Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder.

+ cite this

+ View Abstract

Tharmalingam S, King N, De Luca V, Rothe C, Koszycki D, Bradwejn J, Macciardi F, and Kennedy JL

Psychiatric genetics 16(3):93-7, 2006 Jun - Who cited this? | PubMed ID: 16691126 | Fulltext

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

+ cite this

+ View Abstract

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, Abramson BL, Lambert J, Gravel G, and Lespérance F

Psychosomatic medicine 68(1):87-93, 2006 - Who cited this? | PubMed ID: 16449416 | Fulltext

Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.

+ cite this

+ View Abstract

Koszycki D, Torres S, Swain JE, and Bradwejn J

Psychosomatic medicine 67(4):590-5, 2005 - Who cited this? | PubMed ID: 16046372 | Fulltext

Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany.

+ cite this

+ View Abstract

Rothe C, Koszycki D, Bradwejn J, King N, De Luca V, Shaikh S, Franke P, Garritsen H, Fritze J, Deckert J, and Kennedy JL

Neuroscience letters 363(3):276-9, 2004 Jun 17 - Who cited this? | PubMed ID: 15182959 | Fulltext

Sensitivity to cholecystokinin-tetrapeptide in major depression.

+ cite this

+ View Abstract

Koszycki D, Copen J, and Bradwejn J

Journal of affective disorders 80(2-3):285-90, 2004 Jun - Who cited this? | PubMed ID: 15207943 | Fulltext

An open-label trial of interpersonal psychotherapy in depressed patients with coronary disease.

+ cite this

+ View Abstract

Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, and Lespérance F

Psychosomatics 45(4):319-24, 2004 - Who cited this? | PubMed ID: 15232046 | Fulltext

Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.

+ cite this

+ View Abstract

Katzman MA, Koszycki D, and Bradwejn J

Depression and anxiety 20(2):51-8, 2004 - Who cited this? | PubMed ID: 15390214 | Fulltext

Gender differences in anxiety-related traits in patients with panic disorder.

+ cite this

+ View Abstract

Foot M and Koszycki D

Depression and anxiety 20(3):123-30, 2004 - Who cited this? | PubMed ID: 15487017 | Fulltext

Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.

+ cite this

+ View Abstract

Flint A, Bradwejn J, Vaccarino F, Gutkowska J, Palmour R, and Koszycki D

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 27(4):663-71, 2002 Oct - Who cited this? | PubMed ID: 12377403 | Fulltext

The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.

+ cite this

+ View Abstract

Le Mellédo JM, Arthur H, Dalton J, Woo C, Lipton N, Bellavance F, Koszycki D, Boulenger JP, and Bradwejn J

Journal of psychosomatic research 51(3):513-20, 2001 Sep - Who cited this? | PubMed ID: 11602221 | Fulltext

Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide.

+ cite this

+ View Abstract

Le Mellédo JM, Bradwejn J, Koszycki D, Bellavance F, and Bichet D

Peptides 22(8):1349-57, 2001 Aug - Who cited this? | PubMed ID: 11457531 | Fulltext

Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder.

+ cite this

+ View Abstract

Koszycki D and Bradwejn J

Psychiatry research 101(2):137-43, 2001 Mar 25 - Who cited this? | PubMed ID: 11286817 | Fulltext

Cholecystokinin and panic disorder: past and future clinical research strategies.

+ cite this

+ View Abstract

Bradwejn J and Koszycki D

Scandinavian journal of clinical and laboratory investigation. Supplementum 234:19-27, 2001 - Who cited this? | PubMed ID: 11713976 | Fulltext

A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects.

+ cite this

+ View Abstract

Bradwejn J, Zhou Y, Koszycki D, and Shlik J

Journal of clinical psychopharmacology 20(6):680-4, 2000 Dec - Who cited this? | PubMed ID: 11106141 | Fulltext

Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.

+ cite this

+ View Abstract

Flint AJ, Koszycki D, Bradwejn J, and Vaccarino FJ

Psychoneuroendocrinology 25(6):633-47, 2000 Aug - Who cited this? | PubMed ID: 10840174 | Fulltext

Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers.

+ cite this

+ View Abstract

Shlik J, Zhou Y, Koszycki D, Vaccarino FJ, and Bradwejn J

Journal of psychopharmacology (Oxford, England) 13(4):385-90, 1999 Dec - Who cited this? | PubMed ID: 10667615 | Fulltext

Investigation of cholecystokinin system genes in panic disorder.

+ cite this

+ View Abstract

Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, and Fourie O

Molecular psychiatry 4(3):284-5, 1999 May - Who cited this? | PubMed ID: 10395221 | Fulltext

Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.

+ cite this

+ View Abstract

Le Mellédo JM, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, Steinberg S, Bichet DG, and Bradwejn J

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20(1):81-91, 1999 Jan - Who cited this? | PubMed ID: 9885787 | Fulltext

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.

+ cite this

+ View Abstract

Le Mellédo JM, Bradwejn J, Koszycki D, Bichet DG, and Bellavance F

Biological psychiatry 44(5):364-6, 1998 Sep 1 - Who cited this? | PubMed ID: 9755359 | Fulltext

MMPI scales for diagnosing acute and chronic PTSD in civilians. Minnesota Multiphasic Personality Inventory.

+ cite this

+ View Abstract

Gaston L, Brunet A, Koszycki D, and Bradwejn J

Journal of traumatic stress 11(2):355-65, 1998 Apr - Who cited this? | PubMed ID: 9565920 | Fulltext

Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.

+ cite this

+ View Abstract

Bradwejn J, LeGrand JM, Koszycki D, Bates JH, and Bourin M

The American journal of psychiatry 155(2):280-2, 1998 Feb - Who cited this? | PubMed ID: 9464212 | Fulltext

Effect of aging on cholecystokinin-induced panic.

+ cite this

+ View Abstract

Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, and Bradwejn J

The American journal of psychiatry 155(2):283-5, 1998 Feb - Who cited this? | PubMed ID: 9464213 | Fulltext

Decrease in short-term memory function induced by CCK-4 in healthy volunteers.

+ cite this

+ View Abstract

Shlik J, Koszycki D, and Bradwejn J

Peptides 19(6):969-75, 1998 - Who cited this? | PubMed ID: 9700743 | Fulltext

Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

+ cite this

+ View Abstract

Koszycki D, Zacharko RM, Le Mellédo JM, and Bradwejn J

Depression and anxiety 8(1):1-7, 1998 - Who cited this? | PubMed ID: 9750972 | Fulltext

Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.

+ cite this

+ View Abstract

Koszycki D, Zacharko RM, Le Melledo JM, Young SN, and Bradwejn J

Biological psychiatry 40(7):648-55, 1996 Oct 1 - Who cited this? | PubMed ID: 8886299 | Fulltext

MMPI profiles of acute and chronic PTSD in a civilian sample.

+ cite this

+ View Abstract

Gaston L, Brunet A, Koszycki D, and Bradwejn J

Journal of traumatic stress 9(4):817-32, 1996 Oct - Who cited this? | PubMed ID: 8902748 | Fulltext

Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder.

+ cite this

+ View Abstract

Koszycki D, Zacharko RM, and Bradwejn J

Psychiatry research 62(2):131-8, 1996 May 17 - Who cited this? | PubMed ID: 8771610 | Fulltext

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, and Sedman A

Biological psychiatry 38(11):742-6, 1995 Dec 1 - Who cited this? | PubMed ID: 8580227 | Fulltext

Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide.

+ cite this

Le Melledo JM, Bradwejn J, Koszycki D, and Bichet D

Archives of general psychiatry 52(7):605-6, 1995 Jul - Who cited this? | PubMed ID: 7598637 | Fulltext

Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.

+ cite this

+ View Abstract

Zacharko RM, Koszycki D, Mendella PD, and Bradwejn J

Progress in neurobiology 47(4-5):371-423, 1995 - Who cited this? | PubMed ID: 8966211 | Fulltext

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, and Westenberg H

Archives of general psychiatry 51(6):486-93, 1994 Jun - Who cited this? | PubMed ID: 8192551 | Fulltext

The cholecystokinin hypothesis of anxiety and panic disorder.

+ cite this

Bradwejn J and Koszycki D

Annals of the New York Academy of Sciences 713:273-82, 1994 Mar 23 - Who cited this? | PubMed ID: 8185169 | Fulltext

Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, Couëtoux du Tertre A, Paradis M, and Bourin M

Psychopharmacology 114(2):257-61, 1994 Mar - Who cited this? | PubMed ID: 7838917 | Fulltext

Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.

+ cite this

+ View Abstract

Bradwejn J and Koszycki D

The American journal of psychiatry 151(2):261-3, 1994 Feb - Who cited this? | PubMed ID: 8296900 | Fulltext

Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.

+ cite this

+ View Abstract

Koszycki D, Cox BJ, and Bradwejn J

The American journal of psychiatry 150(12):1881-3, 1993 Dec - Who cited this? | PubMed ID: 8238648 | Fulltext

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, and Karkanias C

Biological psychiatry 32(10):903-12, 1992 Nov 15 - Who cited this? | PubMed ID: 1467375 | Fulltext

Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, Payeur R, Bourin M, and Borthwick H

The American journal of psychiatry 149(7):962-4, 1992 Jul - Who cited this? | PubMed ID: 1609879 | Fulltext

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, and Shriqui C

Archives of general psychiatry 48(7):603-10, 1991 Jul - Who cited this? | PubMed ID: 2069490 | Fulltext

Dose ranging study of the effects of cholecystokinin in healthy volunteers.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, and Bourin M

Journal of psychiatry & neuroscience : JPN 16(2):91-5, 1991 Jul - Who cited this? | PubMed ID: 1911739 | Fulltext

Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers.

+ cite this

+ View Abstract

Koszycki D, Bradwejn J, and Bourin M

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1(2):137-41, 1991 May - Who cited this? | PubMed ID: 1821703 | Fulltext

Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.

+ cite this

+ View Abstract

Bradwejn J and Koszycki D

Progress in neuro-psychopharmacology & biological psychiatry 15(2):237-9, 1991 - Who cited this? | PubMed ID: 1908105 | Fulltext

[Is cholecystokinin a biological support in panic attacks?].

+ cite this

+ View Abstract

Bourin M, Bradwejn J, and Koszycki D

L'Encephale 17(5):475-9, 1991 - Who cited this? | PubMed ID: 1686250 | Fulltext

Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.

+ cite this

+ View Abstract

Bradwejn J, Shriqui C, Koszycki D, and Meterissian G

Journal of clinical psychopharmacology 10(6):403-8, 1990 Dec - Who cited this? | PubMed ID: 2126794 | Fulltext

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.

+ cite this

+ View Abstract

Bradwejn J, Koszycki D, and Meterissian G

Canadian journal of psychiatry. Revue canadienne de psychiatrie 35(1):83-5, 1990 Feb - Who cited this? | PubMed ID: 2180549 | Fulltext

Search Google Scholar for Koszycki D

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!